Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by mercedesmanon Jul 07, 2021 12:16pm
227 Views
Post# 33505620

Technical Trading update, Money matters and 11 million dead

Technical Trading update, Money matters and 11 million deadI'm seeing a very bullish reverse head and shoulders pattern with a bit of a separated right shoulder, likely as a result of tripping & falling over some option hurdles.

Traders should look to add on a confirmed break-out above .57, with trailing stops at .48 and .44 (should insiders decide that they can squeeze out another round of cheap ones....whilst taking advantage of an apparent complete lack of interest by the investor community in Canada despite the fact that thier product could help a good portion of the estimated more than 11 million souls* that die each and every year (worldwide) from Sepsis).  Note these are pre-re-Covid stats (from 2017), noting of course that CV-19  itself has only resulted in 4M deaths over 18+ months...and has resulted in countless millions of organ damaged long-haulers (survivors) that in all liklihood will be more susceptable to bacterial infections, Sepsis, and organ failure going forward.

MM


*
  • Sepsis is a syndromic response to infection and is frequently a final common pathway to death from many infectious diseases worldwide
  • The global burden of sepsis is difficult to ascertain, although a recent scientific publication estimated that in 2017 there were 48.9 million cases and 11 million sepsis-related deaths worldwide, which accounted for almost 20% of all global deaths (1)
  • In 2017, almost half of all global sepsis cases occurred among children, with an estimated 20 million cases and 2.9 million global deaths in children under five years of age (1)
https://www.who.int/news-room/fact-sheets/detail/sepsis
<< Previous
Bullboard Posts
Next >>